Why is Par Drugs & Che. falling/rising?

As of 19-Sep, Par Drugs & Chemicals Ltd is experiencing a decline in its stock price, currently at 112.67, reflecting a decrease of 5.89 or 4.97%. The stock has underperformed its sector by 4.64% today and, despite being higher than its 5-day, 20-day, 50-day, and 100-day moving averages, it remains below its 200-day moving average. Over the past week, the stock has shown a positive return of 3.71%, but it has significantly underperformed over the longer term, with a 51.86% decline in the past year. The company has a low debt-to-equity ratio and a favorable return on equity of 14.3, indicating a potentially attractive valuation; however, it has faced negative results for the last three consecutive quarters, contributing to its recent price drop.
In the broader market context, the stock's short-term performance of 3.71% over the past week contrasts with the Sensex's return of 0.85%, indicating some resilience in a challenging environment. However, the long-term outlook remains bleak, with a year-to-date decline of 43.35% compared to the Sensex's gain of 7.11%. The company's poor long-term growth, with net sales and operating profit growth rates of only 12.10% and 1.10% respectively over the last five years, alongside a significant drop in profits and consistent underperformance against benchmarks, suggests that investor confidence is waning, leading to the current downward trend in stock price.